Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: An IG-IBD study

Journal of Crohn's and Colitis

Volumn 4, Issue 3, 2010, Pages 291-300

  Bertomoro, Perla ^a   Renna, Sara ^b   Cottone, Mario ^b   Riegler, Gabriele ^c   Bossa, Fabrizio ^d   Giglio, Licio ^e   Pastorelli, Luca ^f   Papi, Claudio ^g   Castiglione, Fabiana ^c   Angelucci, Erika ^h   Pica, Roberta ^h   Di Paolo, Maria Carla ⁱ   D'Incà, Renata ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^e SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g SAN FILIPPO NERI HOSPITAL   (Italy)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

Author keywords

Alternative therapies; CAM; Crohn's disease; IBD; Ulcerative colitis

Indexed keywords

ADULT; ALTERNATIVE MEDICINE; ARTICLE; COLITIS; DIET THERAPY; DRUG USE; ENTERITIS; EXERCISE; FEMALE; GEOGRAPHIC ORIGIN; HERBAL MEDICINE; HOMEOPATHY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUESTIONNAIRE; RELIGION; WELLBEING;

EID: 77955275044     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2009.12.009     Document Type: Article

References (57)

1. Markham A.W., Wilkinson J.M. Complementary and alternative medicines (CAM) in the management of asthma: an examination of the evidence. J Asthma 2004, 41:131-139.
2. Soeken K.L. Selected CAM therapies for arthritis-related pain: the evidence from systematic reviews. Clin J Pain 2004, 20:13-18.
3. Ben Arye E., Ziv M., Frenkel M., Rosenman D. Complementary medicine and psoriasis: linking the patient's outlook with evidence-based medicine. Dermatology 2003, 207:302-307.
4. Molassiotis A., Fernandez-Ortega P., Pud D., Ozden G., Scott J.A., Panteli V., et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005, 16:655-663.
5. Strader D.B., Bacon B.R., Lindsay K.L., La Brecque D.R., Morgan T., Wright E.C., et al. Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol 2002, 97:2391-2397.
6. Carmona-Sánchez R., Tostado-Fernández F.A. Prevalence of use of alternative and complementary medicine in patients with irritable bowel syndrome, functional dyspepsia and gastroesophageal reflux disease. Rev Gastroenterol Mex 2005, 70(4):393-398.
7. Bub S., Brinckmann J., Cicconetti G., Valentine B. Efficacy of an herbal dietary supplement (Smooth Move) in the management of constipation in nursing home residents: a randomized, double-blind, placebo-controlled study. J Am Med Dir Assoc 2006, 7(9):556-561.
8. Kong S.C., Hurlstone D.P., Pocock C.Y., Walkington L.A., Farquharson N.R., Bramble M.G., et al. The incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases. J Clin Gastroenterol 2005, 39:138-141.
9. Menniti-Ippolito F., Bologna E., Gargiulo L., Forcella E., Sabbadini L.L., Raschetti R. Caratteristiche individuali e familiari degli utilizzatori di terapie non convenzionali in Italia. Ann Ist Super Sanità 2004, 40(4):455-461.
10. Bensoussan M., Jovenin N., Garcia B., Vandromme L., Jolly D., Bouché O., et al. Complementary and alternative medicine use by patients with inflammatory bowel disease. Results from a postal survey. Gastroenterol Clin Biol 2006, 30:14-23.
11. Garcia-Planella E., Marin L., Domenech E., Bernal I., Mañosa M., Zabana Y., et al. Use of complementary and alternative medicine and drug abuse in patients with inflammatory bowel disease. Med Clin (Barc) 2007, 128(2):45-48.
12. D'Incà R., Garribba A.T., Vettorato M.G., Martin A., Martines D., Di Leo V., et al. Use of alternative and complementary therapies by inflammatory bowel disease patients in an Italian tertiary referral centre. Dig Liv Dis 2007, 39:524-529.
13. Moser G., Tillinger W., Sachs G., Maier-Dobersberger T., Wyatt J., Vogelsang H., et al. Relationship between the use of unconventional therapies and disease-related concerns: a study of patients with inflammatory bowel disease. J Psychosom Res 1996, 40:503-509.
14. Ausfeld-Hafter B., Hoffmann S., Seibold F., Quattropani C., Heer P., Straumann A. A status of alternative medicine in Crohn disease and ulcerative colitis patients: a questionnaire survey. Forsch Komplementarmed Klass Naturheilkd 2005, 12(3):134-138.
15. Joos S., Rosemann T., Szecsenyi J., Hahn E.G., Willich S.N., Brinkhaus B. Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease. BMC Complement Altern Med 2006, 6-19.
16. Rawsthorne P., Shanahan F., Cronin N.C., Anton P.A., Löfberg R., Bohman L., et al. An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease. Am J Gastroenterol 1999, 94:1298-1303.
17. Nunnally J.C. Psychometric theory 1978, McGraw-Hill, New York. 2nd edn.
18. Helmstadter G.C. Principles of psychological measurement 1964, Appleton-Century Crofts, New Appleton-Century Crofts, New York.
19. Wong A.P., Clark A.L., Garnett E.A., Acree M., Cohen S.A., Ferry G.D., et al. Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey. J Pediatr Gatrsoenterol Nutr 2008, 48:55-60.
20. Li F.X., Verhoef M.J., Best A., Otley A., Hilsden R.J. Why patients with inflammatory bowel disease use or do not use complementary and alternative medicine: a Canadian national survey. Can J Gastroenterol 2005, 19(9):567-573.
21. Scott C.M., Verhoef M.J., Hilsden R.J. Inflammatory bowel disease patients' decision to use complementary therapies: links to existing models of care. Complement Ther Med 2003, 11:22-27.
22. Burgmann T., Rawsthorne P., Bernstein C.N. Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use?. Am J Gastroenterol 2004, 99:889-893.
23. McCann L.J., Newell S.J. Survey of paediatric complementary and alternative medicine use in health and chronic illness. Arch Dis Child 2006, 91:173-174.
24. Langhorst J., Anthonisen I.B., Steder-Neukamm U., Lüdtke R., Spahn G., Michalsen A., et al. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey. Inflamm Bowel Dis 2005, 11(3):287-295.
25. Kane S.V. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther 2006, 23:577-585.
26. Langhorst J., Anthonisen I.B., Steder-Neukamm U., Lüedtke R., Spahn G., Michalsen A., et al. Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use. Complemen Ther Med 2007, 15:30-37.
27. Rembacken B.J., Snelling A.M., Hawkey P.M., Chalmers D.M., Axon A.T. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999, 354:635-639.
28. Kruis W., Fric P., Pokrotnieks J., Lukás M., Fixa B., Kascák M., et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004, 53:1617-1623.
29. Gerasimidis K., McGrogan P., Hassan K., Edwards C.A. Dietary modification, nutritional supplements and alternative medicine in paediatric patients with inflammatory bowel disease. Aliment Pharmacol Ther 2007, 11-30.
30. Hanai H., Kanauchi O., Mitsuyama K., Andoh A., Takeuchi K., Takayuki I., et al. Germinated barley foodstuff prolongs remission in patients with ulcerative colitis. Int J Mol Med 2004, 13:643-647.
31. Galvez J., Rodriguez-Cabezas M.E., Zarzuelo A. Effects of dietary fiber in inflammatory bowel disease. Mol Nutr Food Res 2005, 49:601-608.
32. Shanahan F. Probiotics in inflammatory bowel disease - therapeutic rationale and role. Adv Drug Deliv Rev 2004, 56:809-818.
33. Meister D., Ghosh S. Effect of fish oil enriched enteral diet on inflammatory bowel disease tissues in organ culture: differential effects on ulcerative colitis and Crohn's disease. World J gastroenterol 2005, 11(47):7466-7472.
34. Macdonald A. Omega-3 fatty acids as adjunctive therapy in Crohn's disease. Gastroenterol Nurs 2006, 29(4):295-301.
35. Casellas F., Borruel N., Torrejon A., Varela E., Antolin M., Guarner F., et al. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment Pharmacol Ther 2007, 25(9):1061-1067.
36. Tanaka M., Iwao Y., Sasaki S., Okamoto S., Ogata H., Hibi T., et al. Moderate dietary temperance effectively prevents relapse of Crohn disease: a prospective study of patients in remission. Gastroenterol Nurs 2007, 30(3):202-210.
37. Keys A., Aravanis C., Van Buchem H., Blackburn H. The diet and all causes death rate in the seven countries study. Lancet 1981, 2:58-61.
38. Willett W.C., Sacks F., Trichopoulou A., Drescher G., Ferro-Luzzi A., Helsing E., et al. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr 1995, 61:1402-1406.
39. De Lorgeril M., Salen P., Martin J.L., Monjaud I., Delaye J., Mamelle N. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon diet heart study. Circulation 1999, 99:785-799.
40. Gerber M. Olive oil and cancer. Epidemiology of diet and cancer 1994, 263-275. Ellis Horwood, Chichester. M.J. Hill, A. Giacosa, C.P.G. Caygill (Eds.).
41. Reifen R., Nur T., Matas Z., Halpern Z. Lycopene supplementation attenuates the inflammatory status of colitis in a rat model. Int J Vitam Nutr Res 2001, 71(6):347-351.
42. Kaplan M., Mutlu E.A., Benson M., Fields J.Z., Banan A., Keshavarzian A. Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders. Complement Ther Med 2007, 15:207-216.
43. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-kappaB. Annu Rev Cell Biol 1994, 10:405-455.
44. Meraviglia M.G. The effects of spirituality on well-being of people with lung cancer. Oncol Nurs Forum 2004, 31:89-94.
45. Antonovsky A. Health, stress and coping 1979, Jossey Bass, London.
46. Kobassa S. Stressful life events, personality and health: an inquiry into hardiness. J Pers Soc Psychol 1979, 37:1-11.
47. Hert K. Fostering hope in terminally ill people. J Adv Nurs 1990, 15:1250-1259.
48. Gardner R. Miracles of healing in Anglo-Celtic Northumbria as recorded by Venerable Bede and his contemporaries: a reappraisal in the light of twentieth century experience. BMJ 1983, 287(6409):1927-1933.
49. Loudon C.P., Corroll V., Butcher J., Rawsthorne P., Bernstein C.N. The effects of physical exercise on patients with Crohn's disease. Am J Gastroenterol 1999, 94(3):697-703.
50. Langhorst J., Mueller T., Luedtke R., Franken U., Paul A., Michalsen A., et al. Effects of a comprehensive lifestyle modification program on quality of life in patients with ulcerative colitis: a twelve-month follow up. Scand J Gastroentrol 2007, 42(6):734-745.
51. D'Incà R., Varnier M., Mestriner C., Martines D., D'Odorico A., Sturniolo G.C. Effect of moderate exercise on Crohn's disease patients in remission. Ital J Gastroenterol Hepatol 1999, 31:205-210.
52. Kasimay O., Guzel E., Gemici A., Abdyli A., Sulovari A., Ercan F., et al. Colitis-induced oxidative damage of the colon and skeletal muscle is ameliorated by regular exercise in rats: the anxiolytic role of exercise. Exp Physiol 2006, 91(5):897-906.
53. Mawdsley J.E., Rampton D.S. The role of psychological stress in inflammatory bowel disease. Neuroimmunomodulation 2006, 13(5-6):327-336.
54. Langmead L., Chitnis M., Rampton D.S. Use of complementary therapies by patients with IBD may indicate psychosocial distress. Inflamm Bowel Dis 2002, 8:174-179.
55. Kuroki T., Ohta A., Aoki Y., Kawasaki S., Sugimoto N., Ootani H., et al. Stress maladjustment in the pathoetiology of ulcerative colitis. J Gastroenterol 2007, 42(7):522-527.
56. Langmead L., Rampton D.S. Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther 2006, 23(3):341-349.
57. Neuman M. Effects metaboliques et interaction medicamenteuses provoquées par certain substances d'origine vegetale: pamplemousse, millepertuis et ail. Presse Med 2002, 31:1416-1422.